{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:11:54Z","timestamp":1791263514457,"version":"4.1.0"},"reference-count":33,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.3892\/ijo.2012.1675","type":"journal-article","created":{"date-parts":[[2012,10,24]],"date-time":"2012-10-24T06:30:15Z","timestamp":1351060215000},"page":"179-187","source":"Crossref","is-referenced-by-count":18,"title":["The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development"],"prefix":"10.3892","volume":"42","author":[{"given":"CANDACE E.","family":"CARROLL","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YAYUN","family":"LIANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"INDIRA","family":"BENAKANAKERE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CYNTHIA","family":"BESCH-WILLIFORD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SALMAN M.","family":"HYDER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2012,10,24]]},"reference":[{"key":"key20180107181257_b1-ijo-42-01-0179","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/jnci\/92.4.328","article-title":"Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin","volume":"92","author":"Ross","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"key20180107181257_b2-ijo-42-01-0179","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/jama.283.4.485","article-title":"Menopausal estrogen and estrogen progestin replacement therapy and breast cancer risk","volume":"283","author":"Schairer","year":"2000","journal-title":"JAMA"},{"key":"key20180107181257_b3-ijo-42-01-0179","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1001\/jama.289.24.3254","article-title":"Relationship between long durations and different regimens of hormone therapy and risk of breast cancer","volume":"289","author":"Li","year":"2003","journal-title":"JAMA"},{"key":"key20180107181257_b4-ijo-42-01-0179","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/jama.2010.1500","article-title":"Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women","volume":"304","author":"Chlebowski","year":"2010","journal-title":"JAMA"},{"key":"key20180107181257_b5-ijo-42-01-0179","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jsbmb.2004.12.011","article-title":"p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells","volume":"93","author":"Liang","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"key20180107181257_b6-ijo-42-01-0179","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1210\/en.2005-0103","article-title":"Proliferation of endothelial and tumor epithelial cells by progestin-induced vascular endothelial growth factor from human breast cancer cells: paracrine and autocrine effects","volume":"146","author":"Liang","year":"2005","journal-title":"Endocrinology"},{"key":"key20180107181257_b7-ijo-42-01-0179","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1158\/1078-0432.CCR-06-0427","article-title":"Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats","volume":"12","author":"Benakanakere","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20180107181257_b8-ijo-42-01-0179","doi-asserted-by":"crossref","first-page":"9929","DOI":"10.1158\/0008-5472.CAN-07-1103","article-title":"Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor theraputics","volume":"67","author":"Liang","year":"2007","journal-title":"Cancer Res"},{"key":"key20180107181257_b9-ijo-42-01-0179","first-page":"146","article-title":"The molecular biology of RU-486. Is there a role for anti-progestins in the treatment of breast cancer?","volume":"12","author":"Horwitz","year":"1992","journal-title":"Endocr Rev"},{"key":"key20180107181257_b10-ijo-42-01-0179","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.critrevonc.2009.01.001","article-title":"Hypoxia-inducible factor in cancer angiogenesis: structure, regulation and clinical perspectives","volume":"70","author":"Otrock","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20180107181257_b11-ijo-42-01-0179","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/28867","article-title":"Role of HIF-1[alpha] in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis","volume":"394","author":"Carmeliet","year":"1998","journal-title":"Nature"},{"key":"key20180107181257_b12-ijo-42-01-0179","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","article-title":"Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1","volume":"16","author":"Forsythe","year":"1996","journal-title":"Mol Cell Biol"},{"key":"key20180107181257_b13-ijo-42-01-0179","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.anireprosci.2006.11.012","article-title":"Progesterone induces the expression of vascular endothelial growth factor (VEGF) 120 and Flk-1, its receptor, in bovine granulose cells","volume":"102","author":"Shimizu","year":"2007","journal-title":"Anim Reprod Sci"},{"key":"key20180107181257_b14-ijo-42-01-0179","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1023\/A:1026544214667","article-title":"HIF-1: using two hands to flip the angiogenic switch","volume":"19","author":"Semenza","year":"2000","journal-title":"Cancer Metastasis Rev"},{"key":"key20180107181257_b15-ijo-42-01-0179","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0006-2952(01)00564-0","article-title":"Inhibitory effect of YC-1 on the hypoxic induction of erythropoietin and vascular endothelial growth factor in Hep3B cells","volume":"61","author":"Chun","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"key20180107181257_b16-ijo-42-01-0179","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1006\/bbrc.2000.3942","article-title":"YC-1, a benzyl indazole derivative, stimulates vascular cGMP and inhibits neointima formation","volume":"279","author":"Tulis","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107181257_b17-ijo-42-01-0179","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1158\/1535-7163.MCT-05-0090","article-title":"YC-1 suppresses constitutive nuclear factor-kappaB activation and induces apoptosis in human prostate cancer cells","volume":"4","author":"Huang","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"key20180107181257_b18-ijo-42-01-0179","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/jnci\/95.7.516","article-title":"YC-1: A potential anticancer drug targeting hypoxiainducible factor 1","volume":"95","author":"Yeo","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"key20180107181257_b19-ijo-42-01-0179","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/jnci\/82.13.1113","article-title":"Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines","volume":"82","author":"Rubinstein","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"key20180107181257_b20-ijo-42-01-0179","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","article-title":"New colorimetric cytotoxicity assay for anticancer-drug screening","volume":"82","author":"Skehan","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"key20180107181257_b21-ijo-42-01-0179","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/gme.0b013e31814fae5d","article-title":"Curcumin inhibits MPA-induced secretion of VEGF from T47-D human breast cancer cells","volume":"15","author":"Carroll","year":"2008","journal-title":"Menopause"},{"key":"key20180107181257_b22-ijo-42-01-0179","first-page":"392","article-title":"Progestin regulation of vascular endothelial growth factor in human breast cancer cells","volume":"58","author":"Hyder","year":"1998","journal-title":"Cancer Res"},{"key":"key20180107181257_b23-ijo-42-01-0179","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1097\/gme.0b013e3181dd052f","article-title":"Apigenin blocks induction of vascular endothelial growth factor mRNA and protein in progestin-treated human breast cancer cells","volume":"17","author":"Mafuvadze","year":"2010","journal-title":"Menopause"},{"key":"key20180107181257_b24-ijo-42-01-0179","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1677\/ERC-08-0069","article-title":"Regression of progestin-accelerated 7,12-dimethylbenz[a] anthracene-induced mammary tumors in Sprague-Dawley rats by p53 reactivation and induction of massive apoptosis: a pilot study","volume":"16","author":"Benakanakere","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"key20180107181257_b25-ijo-42-01-0179","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/00031305.1981.10479327","article-title":"Rank transformations as a bridge between parametric and nonparametric statistics","volume":"35","author":"Conover","year":"1981","journal-title":"Am Stat"},{"key":"key20180107181257_b26-ijo-42-01-0179","first-page":"32","volume-title":"Comparison among treatment means and analysis of variance","author":"Chew","year":"1977"},{"key":"key20180107181257_b27-ijo-42-01-0179","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/gme.0b013e3181d3dd0c","article-title":"Synthetic progestins induce growth and metastasis of BT-474 human breast cancer xenografts in nude mice","volume":"17","author":"Liang","year":"2010","journal-title":"Menopause"},{"key":"key20180107181257_b28-ijo-42-01-0179","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jsbmb.2004.11.009","article-title":"Inhibition of the 26S proteasome blocks progesterone receptor-dependent transcription through failed recruitment of RNA polymerase II","volume":"94","author":"Dennis","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"key20180107181257_b29-ijo-42-01-0179","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/ijc.1236","article-title":"Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells","volume":"92","author":"Hyder","year":"2001","journal-title":"Int J Cancer"},{"key":"key20180107181257_b30-ijo-42-01-0179","first-page":"121","article-title":"Hypoxia and metastasis in breast cancer","volume":"345","author":"Rundqvist","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"key":"key20180107181257_b31-ijo-42-01-0179","article-title":"Chromatin immunoprecipitation analysis of gene expression in the rat uterus in vivo: estrogen-induced recruitment of both estrogen receptor \u03b1 and hypoxia-inducible factor 1 to the vascular endothelial growth factor promoter","volume":"19","author":"Kazi","year":"2006","journal-title":"Mol Endocrinol"},{"key":"key20180107181257_b32-ijo-42-01-0179","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1124\/jpet.105.085126","article-title":"YC-1 [3-(5\u2032-hydroxymethyl-2\u2032-furyl)-1-benzyindazole] inhibits endothelial cell functions induced by angiogenic factors in vitro and angiogenesis in vivo models","volume":"314","author":"Pan","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"key20180107181257_b33-ijo-42-01-0179","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10549-010-0851-x","article-title":"Targeting mutant p53 protein and the tumor vasculature: an effective combination therapy for advanced breast tumors","volume":"125","author":"Liang","year":"2010","journal-title":"Breast Cancer Res Treat"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2012.1675\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T17:41:06Z","timestamp":1714498866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2012.1675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,24]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,10,24]]},"published-print":{"date-parts":[[2013,1]]}},"alternative-id":["10.3892\/ijo.2012.1675"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2012.1675","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,24]]}}}